10,000+ stock pitches from top investors available on joinyellowbrick.com
RA CAPITAL MANAGEMENT, L.P. 13F Holdings
Holdings from the most recent 13F from RA CAPITAL MANAGEMENT, L.P.
Filed: 2024-05-15 (Q1 2024) | Holdings: 75 | Value: $7.8B | Filing Link
PREMIUM
Author Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Filing Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Holding Returns | |||||||
|---|---|---|---|---|---|---|---|
| Stock | Put/Call | Change | Holding Pct | Value | Current Return | 3M Return | 1Y Return |
| ASND - ASCENDIS PHARMA A/S - ADR | 19.59% | $1.5B | +41.73% | +10.83% | +25.81% | ||
| PCVX - VAXCYTE INC | Add 4% ($21.3M) | 7.19% | $560.4M | -51.32% | +10.37% | -55.45% | |
| LEGN - LEGEND BIOTECH CORP-ADR | Add 10% ($33.5M) | 4.93% | $384.8M | -30.35% | +25.86% | -38.54% | |
| JANX - JANUX THERAPEUTICS INC | 4.42% | $345.1M | -47.52% | -12.42% | -48.54% | ||
| AVTE - AEROVATE THERAPEUTICS INC | 3.13% | $244.4M | -91.62% | ||||
| RYTM - RHYTHM PHARMACEUTICALS INC | 2.96% | $231.0M | +67.08% | +16.33% | +51.30% | ||
| EVH - EVOLENT HEALTH INC - A | Add 125% ($104.5M) | 2.41% | $188.1M | -65.18% | +16.41% | -62.46% | |
| NAMS - NEWAMSTERDAM PHARMA CO NV | 2.38% | $186.0M | -2.69% | -20.05% | -5.84% | ||
| RXST - RXSIGHT INC | Add 1% ($2.0M) | 2.28% | $177.6M | -76.72% | -17.62% | -77.86% | |
| TYRA - TYRA BIOSCIENCES INC | Add 44% ($52.2M) | 2.19% | $170.8M | -44.64% | +18.35% | -45.62% | |
| EWTX - EDGEWISE THERAPEUTICS INC | New Purchase | 2.08% | $162.5M | -16.08% | +4.47% | -16.31% | |
| FDMT - 4D MOLECULAR THERAPEUTICS IN | Add 21% ($28.3M) | 2.06% | $160.9M | -84.47% | -43.17% | -86.34% | |
| BIIB - BIOGEN INC | Add 39% ($44.8M) | 2.05% | $159.7M | -43.71% | -12.82% | -45.77% | |
| PEPG - PEPGEN INC | Add 31% ($37.6M) | 2.01% | $157.1M | -89.66% | -31.25% | -88.78% | |
| GERN - GERON CORP | 1.96% | $152.5M | -59.90% | +15.68% | -67.35% | ||
| ETNB - 89BIO INC | Add 12% ($15.7M) | 1.91% | $148.6M | +7.68% | -13.08% | -15.95% | |
| DYN - DYNE THERAPEUTICS INC | New Purchase | 1.80% | $140.7M | -48.62% | +66.69% | -56.56% | |
| APGE - APOGEE THERAPEUTICS INC | 1.69% | $131.4M | -28.81% | -14.45% | -23.20% | ||
| DAWN - DAY ONE BIOPHARMACEUTICALS I | 1.65% | $129.0M | -57.85% | -15.59% | -62.10% | ||
| NKTX - NKARTA INC | Add 38% ($32.4M) | 1.50% | $116.8M | -73.52% | -26.63% | -74.82% | |
| WVE - WAVE LIFE SCIENCES LTD | 1.44% | $112.3M | +14.60% | -3.57% | +7.47% | ||
| SPRY - ARS PHARMACEUTICALS INC | Add 15% ($14.3M) | 1.42% | $111.0M | +50.67% | +49.44% | +52.47% | |
| FULC - FULCRUM THERAPEUTICS INC | 1.41% | $109.6M | -14.54% | +11.06% | -17.31% | ||
| VRNA - VERONA PHARMA PLC - ADR | 1.30% | $101.7M | +511.00% | +96.36% | +409.36% | ||
| LENZ - LENZ THERAPEUTICS INC | New Purchase | 1.20% | $93.3M | +90.33% | +42.90% | +68.40% | |
| INBX - INHIBRX INC | Reduce 44% $(73.2M) | 1.18% | $91.9M | ||||
| RNA - AVIDITY BIOSCIENCES INC | Add 34% ($21.1M) | 1.07% | $83.8M | +21.38% | +53.41% | +3.51% | |
| AXSM - AXSOME THERAPEUTICS INC | 1.02% | $79.8M | +45.59% | +13.37% | +41.47% | ||
| LBPH - LONGBOARD PHARMACEUTICALS IN | New Purchase | 0.91% | $71.0M | +64.70% | |||
| DNTH - DIANTHUS THERAPEUTICS INC | New Purchase | 0.90% | $70.0M | -35.07% | +0.52% | -31.15% | |
| GHRS - GH RESEARCH PLC | Add 12% ($7.1M) | 0.85% | $66.6M | -2.25% | -22.48% | -14.88% | |
| GPCR - STRUCTURE THERAPEUTICS INC | Add 210% ($43.9M) | 0.83% | $64.7M | -40.34% | +3.14% | -30.06% | |
| MLYS - MINERALYS THERAPEUTICS INC | Add 53% ($21.6M) | 0.80% | $62.6M | +19.69% | -24.83% | +17.62% | |
| ATXS - ASTRIA THERAPEUTICS INC | New Purchase | 0.80% | $62.1M | -43.93% | +20.09% | -57.47% | |
| ABOS - ACUMEN PHARMACEUTICALS INC | 0.78% | $60.5M | -71.77% | -32.19% | -71.77% | ||
| ITOS - ITEOS THERAPEUTICS INC | 0.77% | $60.3M | -43.26% | -16.72% | -56.47% | ||
| SLDB - SOLID BIOSCIENCES INC | Add 26% ($12.0M) | 0.74% | $57.7M | -56.00% | -8.18% | -71.33% | |
| MDGL - MADRIGAL PHARMACEUTICALS INC | 0.70% | $54.6M | +29.36% | +18.37% | +37.32% | ||
| VOR - VOR BIOPHARMA INC | 0.69% | $53.9M | -87.00% | -44.71% | -89.72% | ||
| PRAX - PRAXIS PRECISION MEDICINES I | New Purchase | 0.65% | $50.5M | -4.67% | +19.22% | -16.49% | |
| URGN - UROGEN PHARMA LTD | 0.59% | $46.3M | -62.54% | +7.87% | -46.72% | ||
| LRMR - LARIMAR THERAPEUTICS INC | New Purchase | 0.59% | $45.9M | -68.90% | -4.05% | -74.97% | |
| CTKB - CYTEK BIOSCIENCES INC | 0.59% | $45.7M | -44.98% | -9.56% | -56.01% | ||
| CCCC - C4 THERAPEUTICS INC | 0.51% | $39.9M | -76.29% | -5.65% | -77.74% | ||
| HOWL - WEREWOLF THERAPEUTICS INC | 0.51% | $39.8M | -74.74% | -57.49% | -77.21% | ||
| ELVN - ENLIVEN THERAPEUTICS INC | 0.48% | $37.3M | -10.40% | -0.59% | -29.31% | ||
| ELYM - ELIEM THERAPEUTICS INC | 0.46% | $36.0M | -84.24% | -21.86% | -83.61% | ||
| ACRV - ACRIVON THERAPEUTICS INC | 0.44% | $34.4M | -85.35% | -10.90% | -86.52% | ||
| TSHA - TAYSHA GENE THERAPIES INC | Reduce 41% $(21.8M) | 0.40% | $31.2M | -7.10% | -27.42% | -12.90% | |
| BOLD - BOUNDLESS BIO INC | New Purchase | 0.40% | $31.1M | -87.20% | -63.79% | -81.95% | |
| ALPN - ALPINE IMMUNE SCIENCES INC | Reduce 100% | 0.00% | $0.00 | ||||
| ANTX - AN2 THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| CBAY - CYMABAY THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| ICVX - ICOSAVAX INC | Reduce 100% | 0.00% | $0.00 | ||||
| IMGN - IMMUNOGEN INC | Reduce 100% | 0.00% | $0.00 | ||||
| MGNX - MACROGENICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| PLRX - PLIANT THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| TNYA - TENAYA THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| THRD - THIRD HARMONIC BIO INC | Reduce 100% | 0.00% | $0.00 | ||||